Idorsia Ltd (SWX:IDIA)
0.854
-0.010 (-1.10%)
Feb 21, 2025, 5:31 PM CET
Idorsia Revenue
In the year 2024, Idorsia had annual revenue of 112.51M CHF, down -26.17%. Idorsia had revenue of 59.90M in the quarter ending December 31, 2024, with 178.42% growth.
Revenue
112.51M
Revenue Growth
-26.17%
P/S Ratio
1.38
Revenue / Employee
173.09K
Employees
650
Market Cap
161.19M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 112.51M | -39.88M | -26.17% |
Dec 31, 2023 | 152.39M | 55.28M | 56.93% |
Dec 31, 2022 | 97.10M | 61.75M | 174.70% |
Dec 31, 2021 | 35.35M | -36.41M | -50.74% |
Dec 31, 2020 | 71.76M | 47.94M | 201.26% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Roche Holding AG | 62.40B |
Novartis AG | 46.87B |
Lonza Group AG | 6.57B |
Alcon | 8.25B |
Galderma Group AG | 3.88B |
Straumann Holding AG | 2.50B |
Sandoz Group AG | 9.09B |
Sonova Holding AG | 3.71B |
Idorsia News
- 10 days ago - Idorsia publishes the resolutions for the upcoming bondholder meeting - GlobeNewsWire
- 5 weeks ago - Santhera Pharmaceuticals Provides Update on Royalty Agreement for AGAMREE® (Vamorolone) and Warrants held by Idorsia - GlobeNewsWire
- 5 weeks ago - Idorsia presents at J.P. Morgan Healthcare Conference 2025 – fighting to create value for all stakeholders - GlobeNewsWire
- 5 weeks ago - Idorsia publishes an invitation to a bondholder meeting - GlobeNewsWire
- 5 weeks ago - Idorsia to call for a bondholder meeting - GlobeNewsWire
- 2 months ago - Idorsia provides update on the exclusive negotiations for the global rights to aprocitentan - GlobeNewsWire
- 3 months ago - Swiss pharma firm Idorsia plans debt restructuring, job cuts - Reuters
- 3 months ago - Idorsia enters into exclusive negotiations for global rights to aprocitentan - GlobeNewsWire